Registration - Consultant

Idorsia Pharmaceuticals Canada Ltd / Charles Bernard, Consultant

Registration Information

Client name: Idorsia Pharmaceuticals Canada Ltd
Lobbyist name: Charles Bernard, Consultant
Initial registration start date: 2024-03-26
Registration status: Active
Registration Number: 952477-377601

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 0

Version 1 of 2 (2024-03-26 to 2024-05-14)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Science and Technology
Small Business

Subject Matter Details

Policies or Program

Work to ensure sleep and Chronic Insomnia Disorder (CID) are discussed as a n essential pillar of health in Canada.

Communication Techniques

Written communication
Oral communication
Grass-roots communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Employment and Social Development Canada (ESDC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Senate of Canada
Veterans Affairs Canada (VAC)
Women and Gender Equality (WAGE)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
1155 Metcalfe Street
Suite 1515
Montreal, QC H3B 2V6
Canada

Telephone number: 514-770-6906
Web address: https://www.idorsia.ca/

Client representative

Mike Stamper, Head of Market Access

Parent Company Information

Idorsia Pharmaceuticals Canada Ltd is not a subsidiary of any other parent companies.

Coalition Members Information

Idorsia Pharmaceuticals Canada Ltd is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Idorsia Pharmaceuticals Canada Ltd are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Idorsia Pharmaceuticals Canada Ltd does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Charles Bernard | No public offices held

Business address:
222 Queen St, Suite 1404
Ottawa, ON K1P 5V9
Canada

Telephone number: 819-674-9604

Consultant Firm and Address

Firm: Impact Public Affairs

Address:
222 Queen St, Suite 1404
Ottawa, ON K1P 5V9
Canada

Telephone number: 819-674-9604

Idorsia Pharmaceuticals Canada Ltd/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Idorsia Pharmaceuticals Canada Ltd/	2024-05-14	current
Idorsia Pharmaceuticals Canada Ltd/	2024-03-26	2024-05-14

Idorsia Pharmaceuticals Canada Ltd

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-10-09

Search and menus

Language selection

Registration - Consultant

Idorsia Pharmaceuticals Canada Ltd / Charles Bernard, Consultant

Registration Information

Associated Communications

Version 1 of 2 (2024-03-26 to 2024-05-14)

Version 1 of 2 (2024-03-26 to 2024-05-14)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address